Treatment of Anorexia Nervosa with Palmitoylethanoamide

This hypothesis is grounded on evidence that the endocannabinoid system (ECS) is intimately involved in the pathogenesis of anorexia nervosa (AN). The premise for suggesting that palmitoylethanoamide (PEA), which is a commercially available nutraceutical could ameliorate these disorders, is based the parable of the drunkard who is searching tirelessly under a streetlamp in the nighttime. A policeman approaches, and asks what he has lost. “My keys” he answers, and so the policeman helps him search.
Source: Medical Hypotheses - Category: Biomedical Science Authors: Source Type: research